SS-31 (Elamipretide): Mitochondrial Targeting and Cardioprotection Research
Investigating SS-31 — a Szeto-Schiller tetrapeptide that selectively targets the inner mitochondrial membrane, studied for its role in mitochondrial bioenergetics and cardioprotection.
SS-31: Design and Discovery
SS-31 (also known as elamipretide or MTP-131) belongs to the Szeto-Schiller class of aromatic-cationic tetrapeptides. These peptides were designed to selectively target and concentrate in the inner mitochondrial membrane, achieving cellular concentrations 100- to 1000-fold higher than extracellular levels. This remarkable mitochondrial tropism is driven by the negative membrane potential across the inner mitochondrial membrane (−150 to −180 mV).
Cardiolipin: The Molecular Target
The primary molecular target of SS-31 is cardiolipin, a phospholipid unique to the inner mitochondrial membrane. Cardiolipin plays critical roles in mitochondrial function:
- Electron transport chain: Stabilizes respiratory supercomplexes (Complex I/III/IV)
- Cytochrome c anchoring: Prevents cytochrome c release, a key step in apoptosis initiation
- Membrane curvature: Maintains cristae architecture essential for oxidative phosphorylation
- Protein import: Facilitates mitochondrial protein translocation
Cardiolipin is particularly susceptible to oxidative damage due to its high content of unsaturated fatty acids. Peroxidation of cardiolipin disrupts each of these functions and is a key event in mitochondrial dysfunction.
Mechanism of Action
SS-31 binds to cardiolipin through electrostatic and hydrophobic interactions:
- The positively charged amino acid side chains interact with the negatively charged phosphate head groups of cardiolipin
- The aromatic residues insert into the lipid bilayer adjacent to cardiolipin
- This interaction stabilizes cardiolipin, protecting it from oxidative damage
- Cytochrome c peroxidase activity is inhibited, preserving electron transport
- Mitochondrial reactive oxygen species (ROS) production decreases
Research Applications
Current research investigates SS-31 in:
- Ischemia-reperfusion injury models: Cardiac, renal, and cerebral protection
- Heart failure research: Mitochondrial bioenergetics in failing myocardium
- Neurodegenerative disease models: Mitochondrial dysfunction in Parkinson's and Alzheimer's
- Aging research: Mitochondrial theories of aging and sarcopenia
- Metabolic disease: Insulin resistance and mitochondrial efficiency
Experimental Considerations
- SS-31 is water-soluble and cell-permeable without carrier molecules
- Typical in vitro concentrations range from 1-100 nM
- Effects on mitochondrial oxygen consumption can be measured using Seahorse or Oroboros instruments
- In vivo research typically uses subcutaneous or intraperitoneal administration
- Peptide stability in solution should be verified for long-term experiments
Malice Research Lab supplies SS-31 (2S10, 2S50) with verified purity for mitochondrial biology and cardioprotection research.